Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-31 Purchase |
2025-04-02 4:37 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
16,497 | $12.83 | $211,736 | 1,068,701 (Indirect) |
View |
2025-03-26 Purchase |
2025-03-28 4:51 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
900,000 | $13 | $11,700,000 | 1,066,764 (Indirect) |
View |
2024-12-23 Purchase |
2024-12-26 4:28 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
47,520 | $11.09 | $527,174 | 960,554 (Indirect) |
View |
2024-12-03 Purchase |
2024-12-05 4:36 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
42,000 | $9.6 | $403,200 | 955,124 (Indirect) |
View |
2024-11-19 Purchase |
2024-11-21 4:24 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
41,436 | $10.05 | $416,616 | 950,314 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-09-26 Exercise |
2024-09-30 5:17 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
5,181,347 | $3.86 | 4,758,835 (Indirect) |
View |
2024-09-26 Exercise |
2024-09-30 5:17 pm |
2022-12-09 2027-12-09 |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
16,549,527 | $0 | 4,758,835 (Indirect) |
View |
2024-09-26 Exercise |
2024-09-30 5:17 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
1,368,180 | $0.0001 | 4,758,835 (Indirect) |
View |
2024-09-26 Exercise |
2024-09-30 5:17 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
588,236 | $1.9299 | 4,758,835 (Indirect) |
View |
Ownership |
2024-05-02 5:27 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Cowen Aaron Averill Madison Master Fund Ltd. Averill Master Fund Ltd. 10% Owner |
0 | $0 | 15,233,011 (Indirect) |
View |